Company / Operating Cash Flow
Fortress Biotech, Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$80.2M
FY2025
5-year range
-$179.4M / -$80.2M
FY2021-FY2025
Trend
+37.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$179M in FY2023 to -$16M in FY2016.
Based on SEC 10-K filings.
-$80M in FY2025.
Improved from -$179M to -$80M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 37.5% year-over-year.
- Peak operating cash flow was recorded in FY2016.
- Lowest operating cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$80.2M | +37.5% |
| FY2024 | -$128.2M | +28.5% |
| FY2023 | -$179.4M | -53.9% |
| FY2022 | -$116.5M | -39.3% |
| FY2021 | -$83.7M | +11.9% |
| FY2020 | -$95.0M | +3.9% |
| FY2019 | -$98.8M | -21.6% |
| FY2018 | -$81.3M | -299.0% |
| FY2017 | -$20.4M | -24.8% |
| FY2016 | -$16.3M | +44.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026